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ABSTRACT: Senile plaques composed of amyloid-β protein (Aβ)
are an unshakable feature of the Alzheimer’s disease (AD) brain.
Although there is significant debate on the role of the plaques in AD
progression, there is little disagreement on their role in stimulating a
robust inflammatory response within the context of the disease.
Significant inflammatory markers such as activated microglia and
cytokines are observed almost exclusively surrounding the plaques.
However, recent evidence suggests that the plaque exterior may
contain a measurable level of soluble Aβ aggregates. The
observations that microglia activation in vivo is selectively stimulated
by distinct Aβ deposits led us to examine what specific form of Aβ is
the most effective proinflammatory mediator in vitro. We report
here that soluble prefibrillar species of Aβ(1−42) were better than
fibrils at inducing microglial tumor necrosis factor α (TNFα)
production in either BV-2 and primary murine microglia. Reconstitution of Aβ(1−42) in NaOH followed by dilution into F-12
media and isolation with size exclusion chromatography (SEC) revealed classic curvilinear β-sheet protofibrils 100 nm in length.
The protofibrils, but not monomers, markedly activated BV-2 microglia. Comparisons were also made between freshly isolated
protofibrils and Aβ(1−42) fibrils prepared from SEC-purified monomer. Surprisingly, while isolated fibrils had a much higher
level of thioflavin T fluorescence per mole, they were not effective at stimulating either primary or BV-2 murine microglia
compared to protofibrils. Furthermore, SEC-isolated Aβ(1−40) protofibrils exhibited significantly less activity than
concentration-matched Aβ(1−42). This report is the first to demonstrate microglial activation by SEC-purified protofibrils,
and the overall findings indicate that small, soluble Aβ(1−42) protofibrils induce much greater microglial activation than mature
insoluble fibrils.
KEYWORDS: Alzheimer’s disease, inflammation, amyloid-beta protein, tumor necrosis factor alpha, protofibrils, fibrils

A

accumulated Aβ has been suggested as one of the underlying
mechanisms of progressive neurodegeneration in AD8 and may
in fact exacerbate Aβ deposition.9 Multiple studies suggest that
small Aβ(1−42) oligomers may cause early and significant
alterations in synaptic function and then as fibrillar structures are
produced, concomitant inflammatory responses appear (reviewed
in ref 4).
In vitro Aβ aggregation studies have contributed significantly
to the understanding of fibrillogenesis mechanisms and the
structural properties of monomers, soluble intermediates, and
mature fibrils. These studies have identified a continuum of Aβ
species in the assembly process which vary in their size, length,
solubility, and morphology.10−14 In solution, Aβ monomers
will undergo noncovalent self-assembly15 to form soluble oligomers,16 protofibrils12 that are enriched in β-sheet structure,13
and insoluble fibrils.17 The types of intermediates formed during
fibrillogenesis are dependent on the solution conditions.12,16

lzheimer’s disease (AD) is a complex neurodegenerative
disease characterized by the accumulation of protein deposits in the affected brain and progressive dementia. The two
classic forms of deposits are neurofibrillary tangles composed
of tau protein and dense core neuritic plaques composed of
amyloid-β protein (Aβ).1 Both lesions are believed to
contribute to disease onset and progression although the initial
event appears to be Aβ accumulation.2 Aβ is commonly produced as an unstructured 40- or 42-residue peptide fragment by
proteolytic cleavage of the amyloid-β precursor protein.3 The
monomeric form of Aβ circulates ubiquitously in plasma and
cerebrospinal fluid yet an aggregated fibrillar form comprises
the characteristic Aβ plaques.1 The mechanistic complexity of
AD is increased by the growing number of reports demonstrating a variety of Aβ structures morphologically distinct from
plaques that possess greater solubility and neuronal toxicity.4
It has been well documented that inflammatory markers such
as activated microglia5,6 stained with proinflammatory cytokines7 have been observed surrounding the neuritic Aβ plaques
in the human AD brain. In fact, studies in an AD transgenic
mouse model have shown rapid microglial accumulation around
newly formed plaques.6 A chronic inflammatory state induced by
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Figure 1. Aβ(1−42) structures formed in oligomer- or fibril-forming conditions are morphologically distinct. Aliquots of lyophyllized Aβ(1−42)
were reconstituted to 100 μM as described in the Methods to generate oligomers or fibrils. After 24 h incubation at the given temperatures, aliquots
of the solutions were diluted to 10 μM, applied to mica, and imaged by AFM. Representative images are shown for oligomers (panel A, 5 μm × 5 μm)
and fibrils (panel B, 10 μm × 10 μm). ThT fluorescence measurements (n = 8 for oligomers and n = 10 for fibrils) were obtained for each preparation at a
final concentration of 10 μM Aβ(1−42) (Panel C).

In addition to significant Aβ polymorphism exhibited in the AD
brain, the structural diversity may even extend to the Aβ senile
plaques based on recent observations indicating a significant
level of oligomeric Aβ surrounding the plaques in an AD mouse
model.18
In concert with in vitro aggregation studies, cellular studies
have shown that monomeric, oligomeric, protofibrillar, fibrillar,
and amorphous Aβ species possess distinct toxic and biological
activities and potencies.16,19−22 This is also the case with Aβ as
a proinflammatory stimulus. It is generally felt that soluble Aβ
oligomers and protofibrils contribute to early dendritic and
synaptic injury in AD models (reviewed in ref 23) while fibrillar
Aβ acts as a proinflammatory stimulus. However, many groups
have reported induction of proinflammatory cytokines and
signaling pathways by soluble prefibrillar species in glial cells. In
some cases, the type and extent of proinflammatory response
differed between Aβ fibrils and soluble oligomeric species.24,25
The prevailing view is still that while small soluble Aβ species
display greater cellular toxicity, fibrillar structures are the
primary mediators of inflammation. Our own studies have
indicated that soluble Aβ(1−42) fibrillar precursors were much
more effective than fibrils at stimulating tumor necrosis factor α
(TNFα) production in human monocytes.26 In many reports,
Aβ solutions were used that likely contained a high degree of
polydispersity with respect to size and aggregation state. In this
study, multiple aggregation conditions were evaluated in conjunction with separation and rigorous characterization of the
isolates in order to identify the optimal Aβ species for microglia
activation.

atomic force microscopy (AFM) (Figure 1A). The images were
similar to those of Stine et al.14 Small punctate globular species
were observed in the oligomer preparations (heights 3.1 ± 1.2 nm
for n = 100 measurements) while long flexible fibers (heights
2.7 ± 0.9 nm for n = 100 measurements) were observed in the
fibril preparations. ThT binding and fluorescence levels were
significantly higher in the solutions containing fibrils compared
to those containing oligomers (Figure 1B). This was consistent
with the general understanding of fibrils as they are expected to
have increased β-sheet character and a higher number of ThT
binding sites. However, the observation that the oligomer
preparations exhibited a considerable level of ThT fluorescence
was somewhat surprising and suggested a significant level of
β-structure.
The Aβ(1−42) oligomer and fibril preparations were evaluated for their ability to stimulate TNFα production by microglia. TNFα is an important product of the MyD88-dependent
proinflammatory innate immune response35 and is measurably
increased in post-mortem AD brain sections,7 and microvessels36
and cerebrospinal fluid37 of clinically diagnosed AD patients.
Although most studies show similar responses between BV-2 and
primary microglia, concerns have been raised that in some cases
immortalized BV-2 microglia may not fully model primary
microglia38 and caution should be exercised when interpreting
BV-2 results until direct comparison with primary cells can be
made.39 Therefore, it has become commonplace to utilize both
microglial cell types for experimental testing which was the case
in these studies. A 6 h incubation of 15 μM Aβ(1−42) oligomers
or fibrils with murine microglia revealed significant differences in
TNFα production between the two Aβ aggregation states
(Figure 2). Similar trends of inflammatory activity were observed
in both primary (Figure 2A) and BV-2 (Figure 2B) microglia.
Despite the lesser ThT fluorescence, the Aβ(1−42) solutions
prepared and incubated in oligomer-forming conditions were
markedly better at inducing TNFα from murine microglia consistent with previous findings in rat astrocytes.25
Characterization of SEC-Isolated Aβ(1−42) Protofibrils
Prepared and Eluted in Supplemented F12. Regardless of
the conditions used to study Aβ(1−42) aggregation there is
always a degree of polydispersity present in the solutions which
likely include monomers, soluble aggregates of many sizes, and
some fibril structures. In order to better define and characterize
the soluble Aβ(1−42) aggregation species, SEC was used for
separation and purification. SEC has been used in numerous
studies to separate protofibrils from monomeric Aβ.11,40 In this

■

RESULTS AND DISCUSSION
Microglial TNFα Production Induced by Aβ(1−42)
Prepared in Oligomer-Forming and Fibril-Forming
Conditions. LaDu and colleagues previously compared the
inflammatory response in rat astrocyte cultures induced by
Aβ incubated in oligomer- or fibril-forming conditions.25 We
utilized their preparation methods and conditions to prepare
Aβ(1−42) solutions that contain species of distinct morphology for evaluation of the inflammatory response in isolated
murine microglia. The preparation of the Aβ species entailed
reconstitution in DMSO followed by dilution into either cold
F12 media (oligomer-forming) or 10 mM HCl (fibril-forming).
A 24 h incubation of the Aβ(1−42) solutions at either 4 °C
(oligomer-forming) or 37 °C (fibril-forming) produced the
anticipated morphologies for both conditions as assessed by
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Figure 4. Structure and morphology of Aβ(1−42) protofibrils. (A)
Freshly isolated Aβ(1−42) protofibrils and monomers after elution
from Superdex 75 in supplemented F-12 were diluted to 5 μM
respectively in supplemented F-12 containing 5 μM ThT, and
fluorescence emission was measured as described in the Methods.
(B) Protofibrils were diluted to 20 μM, applied to a copper formwar
grid, and imaged by TEM at a magnification of 43 000×. The scale bar
represents 100 nm.

Figure 2. Aβ(1−42) oligomers stimulate microglia more effectively
than fibrils. Solutions of Aβ(1−42) oligomers and fibrils prepared as in
Figure 1 legend were incubated with microglia at a final concentration
of 15 μM for 6 h. Secreted TNFα was measured by ELISA in the
conditioned medium collected from treated primary murine microglia
(panel A) and (panel B) BV-2 murine microglia. Data bars represent
the average ± standard (std) error of n = 30 trials (oligomers and
fibrils) for primary microglia and n = 32 trials (oligomers) and n = 33
trials (fibrils) for BV-2 microglia. Control treatments in the presence
of 0.3% DMSO in F-12 media or 1.5 mM HCl produced 40 and 15
pg/mL TNFα, respectively, for primary and BV-2 microglia and were
subtracted from Aβ-stimulated samples. Primary and BV-2 microglia
were stimulated in serum-free and 2% FBS medium, respectively.
Statistical differences between oligomers and fibrils for both sets of
data had p values < 0.001.

F-12 media is not a common Superdex 75 elution buffer such as
Tris or PBS, transmission electron microscopy (TEM) imaging
of the F-12-eluted void peak showed classic short curvilinear
protofibrils11,43 < 100 nm in length (Figure 4B). Dynamic light
scattering (DLS) measurements of the protofibril peak from
seven separate SEC purifications produced an average RH value
of 21 nm with a standard deviation (std dev) of 6 nm (data not
shown). Deconvolution of the average RH values into
histograms by data regularization revealed two predominant
peaks of 4.5 ± 0.9 nm and 20.6 ± 6.5 nm. Peak 1 with the
smaller RH value was observed in 4 of 7 protofibril isolations,
while peak 2 was always observed. Even within isolated Aβ(1−
42) protofibrils, a degree of polydispersity was present as the
peak 2 histogram widths varied from narrow (e.g., 15−20 nm)
to broad (e.g., 8−41 nm) in different experiments.
Microglial TNFα Production by SEC-Isolated Aβ(1−42)
Protofibrils, But Not Monomer. BV-2 murine microglia
were treated with fresh SEC-isolated protofibril and monomer
fractions and examined for their ability to stimulate an inflammatory response. Fraction concentrations were calculated based
on UV absorbance and were used to determine final cellular
treatment concentrations. Protofibrils (15 μM) induced a
substantial level of secreted TNFα while monomers (15 μM)
were much less effective (Figure 5). The presence of contaminating lipopolysaccharide (LPS) in SEC fractions was assessed in
two ways, (1) a cell-free XTT assay in which the presence of
any bacteria in the Aβ samples would be expected to catalyze
reduction of XTT and (2) TNFα production was monitored in
the absence or presence of polymyxin B (PMX-B), a neutralizer
of LPS signaling. The former method revealed no XTT reduction in the presence of Aβ samples and in the latter method it
was observed that PMX-B (100 ng/mL) had no effect on the
Aβ response yet blocked >99% of the LPS (3 ng/mL) response
(data not shown). Thus, neither method showed any indication
of bacterial or LPS presence. The findings demonstrated that
isolated Aβ(1−42) protofibrils were significant stimulators of
BV-2 microglia whereas little stimulation was observed with
purified monomeric Aβ(1−42). The response to Aβ(1−42)
protofibrils was also tested in primary microglia isolated from
newborn (3−4 day old) C57BL/6 mouse pups. Freshly isolated
protofibrils were tested at multiple concentrations (5, 10, 15,
and 20 μM) and exhibited a dose-dependent ability to induce
TNFα production in both primary and BV-2 microglia (Figure 6).
Typically primary microglia were more responsive to Aβ(1−42)

set of experiments, a Superdex 75 column was used for separation. Using a modified version of the NaOH method,41
lyophilized Aβ(1−42) was reconstituted in NaOH followed by
dilution in antibiotic-supplemented F-12 to prevent microbial
growth. The use of F-12 media was retained from the oligomerforming conditions in Figure 1 due to the physiological nature
of the solution and the compatibility with microglial cell treatment.
The Aβ(1−42) solution (250 μM) was centrifuged at 18 000g
and the supernatant was eluted in supplemented F-12 media as
described in the Methods. The Aβ(1−42) elution profile was
monitored by UV absorbance (280 nm) and exhibited characteristic protofibril (void) and monomer (included) peaks (Figure 3).

Figure 3. Dual peaks are observed following SEC elution of Aβ(1−42)
reconstituted in NaOH/F-12. Lyophilization Aβ(1−42) (1 mg) was
brought into solution with NaOH followed by supplemented F-12 media to
a final concentration of 200 μM. The supernatant after centrifugation was
eluted from a Superdex 75 column, and 0.5 mL fractions were collected.
UV absorbance at 280 nm was monitored during the elution (solid line).

The significant Aβ(1−42) void peak was observed without prolonged incubation of the reconstitution solution confirming that
Aβ(1−42) forms protofibrils rapidly under these conditions.42
SEC-purified monomer fractions did not exhibit ThT
fluorescence while protofibril fractions at equivalent concentrations showed significant fluorescence (Figure 4A). Although
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of the pellet as described in the Methods. In all cases, >98% of
the ThT fluorescence of the total solution was removed from
the supernatant after centrifugation. ThT fluorescence comparisons of equivalent concentrations of Aβ(1−42) fibrils and
SEC-purified Aβ(1−42) protofibrils and monomers immediately following elution showed fibrils with by far the best ThT
binding ability (Figure 7A). Protofibrils displayed significantly
lower ThT fluorescence and monomers were at background
levels. TEM images of the isolated Aβ(1−42) fibrils revealed
long fibers with lengths exceeding 1 μm and typical widths of
5−10 nm (Figure 7B). The neutral pH and higher ionic
strength of the F-12 media encouraged a considerable degree of
lateral association between the fibrils. Surprisingly, fibrils were
very poor in their ability to stimulate TNFα production in
primary (Figure 7C) and BV-2 (data not shown) microglia.
Aβ(1−42) protofibrils invoked a dramatically higher microglial
response compared to fibrils and monomers (Figure 7C). A
cell-free XTT cell proliferation assay again showed no evidence
of contamination in any of the preparations (data not shown).
Our typical BV-2 and primary microglial preparations contained
cells with both round and ramified morphologies with defined
boundaries. After exposure to Aβ, the cells became clustered
with rough boundaries and a less ramified morphology. These
observations are consistent with those made by Garcao et al in
rat microglia.44 Primary microglia underwent more pronounced
alterations in morphology compared to BV-2 cells. Even with
these exterior changes to the cells after treatment with Aβ, no
significant toxicity was observed using an XTT cell viability
assay. Exposure of the microglia to Aβ(1−42) fibrils, protofibrils, or monomer for 6 h did not inhibit mitochondrialmediated reduction of XTT in either BV-2 or primary microglia
(data not shown). The preparation of Aβ protofibrils, fibrils,
and monomers in the supplemented F-12, which is similar in
pH and ionic strength to the microglial cell culture medium,
likely helped prevent dramatic structural changes in the isolated
Aβ species when introduced to the microglia cells. Although
this was not verified, very different microglial responses were
clearly able to be observed between the distinct Aβ species.
Comparison of Microglial TNFα Production between
Aβ(1−42) Protofibrils and Aβ(1−40) Protofibrils. In order
to compare Aβ(1−40) protofibrils with those formed from
Aβ(1−42), a longer incubation was needed after NaOH reconstitution and dilution into supplemented F-12 medium. While
Aβ(1−42) protofibrils formed rapidly within minutes, Aβ(1−
40) required a 24 h incubation at 25 °C before significant
amounts of protofibrils were generated (Figure 8). The Aβ(1−
40) protofibril fraction was assessed by TEM which revealed
similar structures as observed for Aβ(1−42) although the
lengths appeared somewhat smaller (Figure 9A). Manual measurements of the images confirmed that the Aβ(1−40) and
Aβ(1−42) protofibril fractions had statistically different (p <
0.001) lengths as Aβ(1−40) protofibrils averaged 27 ± 11 nm
while Aβ(1−42) protofibrils averaged 50 ± 16 nm for n = 50
measurements. The length analysis only included unambiguous
protofibril structures and excluded the smaller species (<15 nm).
Despite morphological similarities, cellular studies demonstrated
that Aβ(1−40) protofibrils were much less effective in stimulating TNFα in primary microglia compared to Aβ(1−42) protofibrils (Figure 9B). The concentration used in the microglial
treatment for both Aβ(1−40) and Aβ(1−42) protofibrils was
15 μM.
The current report demonstrates the substantial activation of
murine microglia by soluble Aβ(1−42) aggregates. We observed

Figure 5. Protofibrils are significant stimulators of BV-2 microglia.
SEC-isolated Aβ(1−42) protofibrils and monomers in supplemented
F-12 were incubated with BV-2 microglia at a final concentration of
15 μM for 6 h in medium containing 2% FBS. Secreted TNFα was
measured by ELISA in the conditioned medium. Data bars represent
the average ± std error of n = 6 trials. Control treatments with an
equal volume of supplemented F-12 media produced 23 pg/mL TNFα
and were subtracted from Aβ-stimulated samples.

Figure 6. Protofibrils display a dose-dependent effect in their ability to
induce TNFα production in microglia. SEC-isolated Aβ(1−42)
protofibrils in supplemented F-12 were incubated with primary
microglia (panel A) or BV-2 microglia (panel B) for 6 h at final
concentrations of 5, 10, 15, and 20 μM. Secreted TNFα was measured
by ELISA in the conditioned medium. Data bars represent the average
± std error of n = 4−6 trials at each concentration for primary
microglia and n = 6 trials at each concentration for BV-2 microglia.
Control treatments with supplemented F-12 media produced 6 and 17
pg/mL TNFα respectively for primary and BV-2 microglia and were
subtracted from Aβ-stimulated samples. Primary and BV-2 microglia
were stimulated by Aβ in serum-free conditions.

protofibrils than BV-2 microglia, but this disparity was
dependent on the age and number of harvests of the primary
cells as well as the BV-2 passage number. In some experiments,
BV-2 cells secreted higher levels in response to Aβ(1−42)
protofibrils.
Comparison of Microglial TNFα Production between
Aβ(1−42) Protofibrils and Fibrils Prepared from SECPurified Monomer. We then sought to compare the microglialactivating ability of protofibrils and fibrils. SEC-purified Aβ(1−42)
monomer in supplemented F-12 was moved to 25 °C and
subjected to gentle agitation for approximately 72 h. Fibrils were
isolated by centrifugation, supernatant removal, and resuspension
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Figure 7. Protofibrils display less ThT fluorescence but stimulate microglia more effectively than fibrils. (A) Aliquots of SEC-purified Aβ(1−42)
protofibrils (PF), monomer (M), and Aβ(1−42) fibrils formed from purified monomer (F) were diluted to 5 μM in 50 mM Tris-HCl pH 8.0
containing 5 μM ThT and fluorescence emission was measured and plotted as described in the Methods. Fibrils were isolated as described after gentle
agitation for 72 h at 25 °C. One fluorescence measurement was obtained from each solution. (B) TEM images of isolated Aβ(1−42) fibril pellets
(74 μM) at a magnification of 25,000. (C) Aliquots of the solutions described in panel (A) were incubated with primary murine microglia for 6 h at a
final concentration of 15 μM Aβ(1−42). Secreted TNFα was measured by ELISA in the conditioned medium. Error bars represent the average ± std
error of n = 6. Control treatments with supplemented F-12 media produced 15 pg/mL TNFα for primary microglia and were subtracted from
Aβ-stimulated samples.

that an enriched fraction of SEC-isolated protofibrils elicited the
greatest production of the proinflammatory cytokine TNFα
compared to monomers and fibrils. The current results have
similarities to our previous findings in THP-1 human monocytes
in which soluble fibrillar precursors were optimal for inducing a
proinflammatory response.26 While many studies have shown
that monocytes and microglia have similar responses to Aβ,
microglial cells provide a more relevant model system for
investigating Aβ neuroinflammatory mechanisms. Furthermore,
this report is the first to provide a direct comparison between
SEC-purified Aβ(1−42) protofibrils and isolated Aβ(1−42)
fibrils prepared from SEC-purified monomer in their ability to
induce microglial activation.
An array of Aβ aggregate morphologies ranging from dense
core neuritic plaques to granular diffuse wispy Aβ deposits are
observed in the AD brain.1 It has been known for some time
that the plaques serve as a focal point for inflammation.5 The
rapid response of microglia to a site of new plaque formation
has been revealed using multiphoton microscopy in a transgenic mouse model outfitted with a cranial window.6 In this case,
as well as others, microglia were not associated with diffuse Aβ
deposits. Although it is not a straightforward extrapolation from
in vitro results to in vivo mechanisms, the findings from our current study may be relevant to recent findings in transgenic mouse
models. Hyman and colleagues observed a halo of oligomeric Aβ
surrounding Aβ plaques based on immunostaining with NAB61
antibody.18 Although the plaques contain fibrillar Aβ at the
core,45 these data suggest that the plaque composition is more
complex than originally thought. There may be dynamic aggregation processes occurring in the plaque environment and the
microglial cells may interact with multiple Aβ species.
Much of the recent emphasis on soluble Aβ aggregates has
been on oligomers yet much more structural information is
known about protofibrils. The first observation and characterization of protofibrils more than a decade ago identified these
small soluble species with significant β-sheet structure13
as precursors to fibrils.10,11 Centrifugation followed by SEC
on Superdex 75 was instrumental in isolating protofibrils for
further characterization.11 Previous size analysis of protofibrils
identified a range of RH values from 10 to 50 nm and lengths of
typically <200 nm.11 The Aβ(1−42) protofibrils characterized
in the current study were within these ranges but on the smaller
end. The observation of bimodal RH peaks in protofibril DLS

Figure 8. Aβ(1−40) protofibrils require longer incubation for
formation. Aβ(1−40) was reconstituted and prepared for SEC as
described in the Methods. Aβ(1−40) solutions were eluted on
Superdex 75 immediately (dashed line) or after a 24 h incubation at
25 °C (solid line). Fractions containing protofibrils and monomers
were immediately placed on ice for further characterization.
Concentrations were determined by UV absorbance.

Figure 9. Aβ(1−40) protofibrils do not stimulate microglia as well as
Aβ(1−42) protofibrils. (A) TEM image of a sample taken from the
Aβ(1−40) protofibril peak in Figure 8 (solid line). Sample was diluted
to 20 μM Aβ, applied to a copper formwar grid as described in the
Methods, and imaged at a magnification of 43 000×. The scale bar
represents 100 nm. (B) Primary microglia were incubated with Aβ(1−40)
or Aβ(1−42) protofibrils isolated by SEC in supplemented F-12 at a
final concentration of 15 μM each for 6 h. Secreted TNFα was
measured by ELISA in the conditioned medium. Data bars represent
the average ± std error of n = 12 (Aβ40) and n = 9 (Aβ42) trials over
two separate protofibril preparations for each protofibril type.
Protofibrils were directly compared within each cell treatment
experiment. Control treatments with an equal volume of supplemented F-12 media produced 31 pg/mL TNFα and were subtracted
from Aβ-stimulated samples.
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(based on NAB61 antibody binding) and the number of reactive
astrocytes was better than the correlation between total Aβ plaque
burden and reactive astrocytes.57
Given the polydispersity observed in Aβ aggregation, there is
a good possibility that many preparations are not homogeneous. In fact, many studies focusing on a particular biological
activity of Aβ utilize Aβ solutions that have not been rigorously
characterized. These solutions likely contain mixtures of Aβ
aggregated species including oligomers, protofibrils, and fibrils.
The conditions can dictate which species is more highly
populated, but the mixture prevents the identification of the
most active species. In fact, the Aβ(1−42) solutions prepared in
fibril-forming conditions (Figures 1 and 2) may have contained
a small population of protofibrils which might help to explain
why a moderate amount of microglial TNFα production was
observed. The formation of these fibrils at very low ionic
strength precluded the ability to utilize centrifugation to separate the fibrils from any contaminating protofibrils. However,
the Aβ(1−42) fibrils prepared from SEC-purified monomer at
physiological pH and ionic strength (Figure 7) were very poor
at stimulating TNFα production from microglia. This
observation was possible due to the additional isolation step
whereby fibrils were separated from the remaining Aβ solution
by centrifugation and resuspended before application to the
cells. This procedure likely removed any soluble aggregated
species that may have been present in the initial solution thus
allowing isolated fibrils to be evaluated. Looking back on
previous studies, the persistent use of Aβ solutions containing a
polydisperse population of aggregated species when evaluating
Aβ biological activity may help to explain significant fluctuations
in cell response and irreproducibility between experiments.
Furthermore, the Aβ(1−42) fibrils described in Figures 1 and 2
were prepared under nonphysiological solution conditions (e.g.,
10 mM HCl), and while the acidic conditions may have
enhanced fibril formation, the internal structure may be quite
different from the fibrils formed under more physiological
conditions in Figure 7. Petkova et al. found that parallel β-sheet
Aβ(1−40) fibrils prepared under different conditions had distinct
hydrogen-bond registries and marked differences in neuronal
toxicity.58 The same phenomenon has been observed for
soluble aggregates. Chiti and co-workers demonstrated that
oligomers grown under different solution conditions can have
identical morphologies yet show different internal structures
and toxicities.59 There remain potential concerns with in vitro
preparation of aggregated Aβ species for cellular studies as
their structure may have important differences from those
formed in vivo. In the current study, the preparation, isolation,
and characterization of Aβ(1−42) protofibrils under close to
physiological solution conditions may help avoid some of the
concerns. The significant and consistent microglial response
to an enriched SEC fraction of Aβ(1−42) protofibrils demonstrates that these soluble fibrillar precursors are potent proinflammatory mediators. The much weaker microglial response to
an equal concentration of Aβ(1−40) protofibrils suggests that
even though the two protofibril species appear morphologically
similar, there are distinct properties between the two types of
protofibrils that influence their inflammatory activity.

regularization histograms suggests that further separation and
characterization may be possible. Structurally, protofibrils have
similarities to fibrils based on thioflavin T binding, circular dichroism,13 and hydrogen exchange,43 but have not yet developed the full stability of fibrillar Aβ.13,43 Protofibril diameters
are typically smaller than fibrils and range from 4 to 6 nm
although the protofibril to fibril transition can occur without a
change in diameter.10 The transition to fibrils can occur via
mechanisms that incorporate monomer deposition on protofibril
ends, end-to-end annealing of protofibrils, and lateral association
of protofibrils.12,34 Protofibrils display toxicity to neurons,13 disrupt ion channels,46 inhibit hippocampal long-term potentiation,47 and are likely to possess other detrimental biological activities. Their solubility and diffusible nature quite possibly render
them more effective in cellular interactions and engaging microglial receptors compared to mature insoluble fibrils.
The mechanism by which Aβ fibrils evoke a proinflammatory
response appears to involve multiple cell-surface receptors. A
multireceptor complex comprising the SR-B receptor CD36,
α6β1-integrin, and the integrin-associated protein CD47 has
been shown to mediate fibrillar Aβ initiation of murine microglial activation.48 Furthermore, receptor components of the innate
immune system including CD14,49 toll-like receptor (TLR) 2, and
TLR 4 have also been identified as proinflammatory-linked
receptors in microglial cells for Aβ fibrils.31 Moreover, a TLR4TLR6-CD36 complex was recently shown to mediate cellular
inflammatory responses to Aβ(1−42) fibrils.50 A cell-surface
receptor that is selective for Aβ protofibrils has not been identified although the known fibril receptors may recognize similar
structural elements between the two species.
For many years, it has been accepted that fibrillar Aβ is the
primary trigger for inducing a glial inflammatory response in
AD and in cell culture models. Many studies established and
utilized solution conditions that were optimal for Aβ fibril formation but may have contained other Aβ species. Nevertheless,
it was generally interpreted as microglial activation by Aβ fibrils.
Numerous studies have demonstrated cytokine production by
fibrillar Aβ,30,51 interaction of fibrillar Aβ with proinflammatory
receptors,48−50 and initiation of proinflammatory signaling
pathways by fibrillar Aβ. 52,53 More recently, studies have
shown that a fibrillar state for Aβ may not be required for
microglial activation. These findings have been based on a lack
of correlation between ThT binding and cell stimulation54 or
modulation of aggregation solution conditions to encourage
formation of oligomers that display significant proinflammatory
activity in microglia.24,25 A recent study altered the Aβ aggregation solution conditions to encourage formation of smaller or
larger oligomers and fibrils. Stimulation of primary mouse
microglia with these solutions revealed that, while polydisperse
in Aβ species, those solutions containing smaller oligomers
were able to induce more TNFα mRNA than those containing
larger oligomers and fibrils.55 Less has been published regarding
Aβ protofibrils and their role in AD-linked inflammation. In
one study, Parvathy et al. found that Aβ protofibrils were not
effective at inducing IL-1α mRNA expression in primary murine
microglia compared to oligomers and fibrils.56 This finding
indicates that perhaps not all microglial proinflammatory products are upregulated to the same extent by Aβ protofibrils. Interestingly, a new report suggests that soluble Aβ aggregates may
be one of the targets of the central nervous system glial cell
response which includes both microglia and astrocytes. DaRochaSouto et al. demonstrated in double-transgenic APPsw-tauvlw mice
that the correlation between oligomeric Aβ burden in the brain

■

METHODS

Cell Culture and Primary Microglia Isolation. BV-2 cells are
primary mouse microglial cells immortalized by stable transfection
with the c-myc oncogene27 and are functionally identical to native
primary microglia.28 BV-2 cells were provided by Dr. Gary Landreth,
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Case Western Reserve University, and were maintained in Dulbecco’s
modified Eagle’s medium (DMEM, 4.5 g/L glucose) (Hyclone)
containing 50 U/mL penicillin, 50 μg/mL streptomycin, 50 μM
β-mercaptoethanol, and 5% fetal bovine serum (FBS, Hyclone). BV-2
cells were used for their ease of culture, initial observations,
optimization of microglia/Aβ interactions, and to reduce the usage
of mice for primary cells. Primary murine microglia were obtained
from newborn C57BL/6 mouse pups as previously described.29 Care
and breeding of the C57BL/6 parent mice (Harlan Laboratories) was
done at the University of MissouriSt. Louis Animal Facility. Briefly,
3−4 day old mouse pups were euthanized with an overdose of inhaled
isoflurane (Fisher Scientific). The brains were isolated and meninges
were removed under sterile conditions. Brain tissue was minced using
sharp edged forceps, resuspended in 0.5% trypsin (Hyclone), and
incubated at 37 °C for 20 min to allow further dissociation of the tissue.
Subsequently, tissue was resuspended in complete DMEM containing 10% fetal bovine serum, 4 mM L-glutamine, 100 U/mL penicillin,
0.1 mg/mL streptomycin and 0.25 μg/mL amphotericin-B (Fisher
Scientific), OPI medium supplement (oxalocetate, pyruvate, insulin,
Sigma-Aldrich), and 0.5 ng/mL recombinant mouse granulocytemacrophage colony-stimulating factor (GM-CSF) (Invitrogen). The
cell suspension was further triturated using a pipet and filtered through
a 70 μm cell strainer to remove debris. The resulting cell suspension
was centrifuged at 200g for 5 min at 25 °C, resuspended in complete
medium, and seeded into 150 cm2 flasks (Corning). Cells were cultured
at 37 °C in 5% CO2 until confluent (1−2 weeks), and microglia were
selectively harvested from the adherent astrocyte layer by overnight
shaking of the flask at 37 °C in 5% CO2 and collection of the medium.
The flasks were replenished with fresh medium and then incubated
further to obtain additional microglia. Typically, this procedure was
repeated 3−4 times for one flask without removal of the astrocyte layer.
Cell Stimulation Assay. For cellular studies, BV-2 microglia were
removed from culture flasks with 0.25% trypsin and seeded in a sterile
96-well cell culture plate overnight at a density of 5 × 105 cells/mL in
growth medium described above. Prior to cell treatment, medium was
replaced with fresh medium containing either 0 or 2% FBS followed by
Aβ stimulation at a final concentration of 15 μM. The inclusion of 2%
FBS initially was adapted from an established THP-1 monocyte protocol.30 Treatment of BV-2 without serum has been reported elsewhere31 and the absence of serum during BV-2 cell stimulation did not
dramatically alter the results. The cells were incubated at 37 °C for 6 h
in 5% CO2, and the medium was collected and stored at −20 °C for
subsequent analysis by enzyme-linked immunosorbent assay (ELISA).
Primary microglia were collected after shaking flasks overnight and
then centrifuged at 200g for 10 min at 25 °C. The cells were resuspended in complete microglial medium without GM-CSF or FBS and
plated at a density of 5 × 105 cells/ml in a sterile 96-well cell culture
plate for either 2 h or overnight. The longer preincubation, which has
been used previously31 and was done to allow greater adherence of the
microglia, had no deleterious effects on the cells. Prior to treatment,
the medium was replaced again and lipopolysaccharide (3 ng/mL) or
Aβ (15 μM) was added to the cells. The medium was collected after
6 h and stored at −20 °C for subsequent determination of secreted
TNFα levels by ELISA. The background cellular response was assessed
using the particular buffer vehicle for the Aβ.
ELISA. Measurement of secreted TNFα in the supernatants was
determined by ELISA as previously detailed.32 Briefly, 96-well plates
were coated overnight with monoclonal antimouse TNFα capture antibody, washed with phosphate-buffered saline (PBS) containing 0.05% Tween-20, and blocked with PBS containing 1% BSA, 5%
sucrose, and 0.05% NaN3 following by a wash step. Successive treatments with washing in between were done with samples or standards,
biotinylated polyclonal antimouse TNFα detection antibody in 20 mM
Tris with 150 mM NaCl and 0.1% BSA, streptavidin-horseradish
peroxidase (HRP) conjugate, and equal volumes of HRP substrates
3,3′,5,5′-tetramethylbenzidine and hydrogen peroxide. The reaction
was stopped by the addition of 1% H2SO4 solution. The optical density of each sample was analyzed at 450 nm with a reference reading at
630 nm using a SpectraMax 340 absorbance plate reader (Molecular
Devices, Union City, CA). The concentration of TNFα in the

experimental samples was calculated from a mouse TNFα standard
curve of 15−2000 pg/mL. When necessary, samples were diluted to
fall within the standard curve. TNFα concentrations for absorbance
values below the lowest 15 pg/mL standard were determined by
extrapolation of the standard curve regression line.
Preparation of Aβ Peptides. Aβ(1−42) was obtained from W.M.
Keck Biotechnology Resource Laboratory (Yale School of Medicine,
New Haven, CT) in lyophilized form and stored at −20 °C. Aβ(1−40)
was obtained from rPeptide (Bogarth, GA) or prepared by solid phase
synthesis in the Structural Biology Core at the University of
MissouriColumbia as described previously.33 Aβ peptides were
typically dissolved in 100% hexafluoroisopropanol (HFIP) (SigmaAldrich, St. Louis, MO) at 1 mM, aliquoted into sterile microcentrifuge
tubes, and evaporated uncovered at room temperature overnight in a
fume hood. The following day, the aliquots were vacuum-centrifuged to
remove any residual HFIP and stored in desiccant at −20 °C. Some Aβ
peptides were treated with 100% trifluoroacetic acid and vacuumcentrifuged prior to HFIP treatment. Aβ oligomers and fibrils obtained
directly from lyzophilized aliquots were prepared as previously
described.14 Briefly, lyophilized Aβ42 aliquots were resuspended in
sterile anhydrous dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis,
MO) at 5 mM. For oligomer preparation the sample was diluted to 100 μM
in sterile ice-cold Ham’s F-12 cell culture medium with L-glutamine
but without phenol red (F-12, Bioworld, Dublin, OH) and incubated for
24 h at 4 °C. For fibril preparation, the sample was diluted to 100 μM in
10 mM HCl and incubated for 24 h at 37 °C. Aβ concentrations in these
preparations were based on dry peptide weight.
Size Exclusion Chromatography. An amount of 1−1.5 mg of
lyophilized Aβ peptide was dissolved in 50 mM NaOH to yield a
2.5 mM Aβ solution. The solution was then diluted to 250 μM Aβ
in sterile prefiltered (0.22 μm) Ham’s F-12 cell culture medium
(described above) with additional supplementation of 100 U/mL
penicillin, 0.1 mg/mL streptomycin, and 0.25 μg/mL amphotericin-B
(heretofore referred to as supplemented F-12). Aβ(1−42) solutions
were centrifuged immediately at 18 000g for 10 min with a BeckmanCoulter Microfuge18 instrument while Aβ(1−40) solutions were
incubated for 24 h at 25 °C prior to size-exclusion chromatography
(SEC). The centrifugation supernatant was eluted from a Superdex 75
HR 10/30 column (GE Healthcare) in supplemented F-12 medium.
Prior to injection of Aβ, Superdex 75 column was coated with 2 mg
bovine serum albumin (BSA, Sigma) to prevent any nonspecific
binding of Aβ to the column matrix. Following a 1 mL loading of the
sample, Aβ was eluted at 0.5 mL/min and 0.5 mL fractions were
collected and immediately placed on ice. Fractions 13, 14 eluting in the
void volume were pooled together and designated as protofibrils while
fractions 24−25 eluting in the included peak were pooled and
designated as monomer. UV absorbance at 280 nm was monitored
continuously in milliabsorbance units (mAU) during the elution, and
concentrations of both protofibrils and monomers were determined
directly from the absorbance trace using an extinction coefficient of
1450 cm−1 M−1 at 280 nm. The delay volume between the absorbance
detector and fraction collector was minimal, and this was verified in
initial experiments by measuring Aβ concentrations in the fractions on
a Cary Bio 50 UV absorbance spectrophotometer and comparing
those concentration values to those determined from the chromatography absorbance trace. Aβ(1−42) fibrils were prepared from SECpurified Aβ(1−42) monomer in supplemented F-12 by incubation at
room temperature under gentle agitation for ∼72 h. The aggregated
Aβ(1−42) solution was then centrifuged at 18 000g for 10 min,
supernatant was removed, and the pellet was resuspended in the same
volume of supplemented F-12. The concentration of fibrils was
assumed to match the original starting concentration of the Aβ(1−42)
monomer. Thioflavin-T (ThT) fluorescence measurements were done
on the total Aβ(1−42) solution, the 18 000 g supernatant, and the
resuspended pellet in order to monitor the conversion of Aβ monomer
into fibrils.
Thioflavin T Fluorescence Measurements. Aβ(1−42) monomer, protofibril and fibril solutions were assessed by ThT fluorescence
as described previously.34 Aβ aliquots were removed and diluted
10-fold into 50 mM Tris-HCl pH 8.0 containing 5 μM ThT. Fluorescence
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emission scans (460−520 nm) were acquired on a Cary Eclipse
fluorescence spectrophotometer using an excitation wavelength of
450 nm and integrated from 470 to 500 nm to obtain ThT relative
fluorescence values. F-12 medium, supplemented or not, did not show
any significant ThT fluorescence in the absence of Aβ. All ThT fluorescence numbers are reported in relative fluorescence units denoted
arbitrary units (a.u.) in the figures.
Atomic Force Microscopy. Aβ(1−42) aggregation solutions
(100 μM) were diluted to 10 μM in water. Grade V1 mica (Ted Pella,
Inc., Redding, CA) was cut into 11 mm circles and affixed to 12 mm
metal discs. Aliquots (50 μL) were applied to freshly cleaved mica,
allowed to adsorb for 15 min, washed twice with water, air-dried, and
stored in a container with desiccant. Images were obtained with a
Nanoscope III multimode atomic force microscope (Digital Instruments, Santa Barbara, CA) in TappingMode. Height analysis was
performed using Nanoscope III software on flattened height mode
images.
Transmission Electron Microscopy. SEC-purified Aβ(1−42)
protofibril and aggregation solutions were diluted to 20 μmol/L in
water unless otherwise stated and applied (10 μL) to a 200-mesh
Formvar-coated copper grid (Ted Pella, Inc.). Samples were allowed
to adsorb for 10 min at 25 °C, followed by removal of excess sample
solution. Grids were washed three times by placing the sample side
down on a droplet of water. Heavy metal staining was done by incubation of the grid on a droplet of 2% uranyl acetate (Electron Microscopy Sciences, Hatfield, PA) for 5 min, removal of excess solution, and
air drying. Affixed samples were visualized with a JEOL JEM-2000 FX
transmission electron microscope operated at 200k eV.
Dynamic Light Scattering. Hydrodynamic radius (RH) measurements were made at room temperature with a DynaPro Titan
instrument (Wyatt Technology, Santa Barbara, CA). Samples (30 μL)
were placed directly into a quartz cuvette and light scattering intensity
was collected at a 90° angle using a 10 s acquisition time. Particle
diffusion coefficients were calculated from autocorrelated light intensity data and converted to RH with the Stokes−Einstein equation.
Average RH values were obtained with Dynamics software (version
6.7.1). Histograms of percent intensity vs RH were generated by
Dynamics data regularization and intensity-weighted mean RH values
were derived from the regularized histograms.
XTT Cell Viability and Proliferation Assay. Viability of
Aβ-treated microglia was determined by using an XTT [2, 3-bis
(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide]
assay. Cellular metabolic activity was monitored by mitochondriamediated reduction of XTT (Sigma). XTT assay was also used in a
cell-free manner to rule out the possibility of any bacterial contamination of Aβ(1−42) and Aβ(1−40) samples. In cellular XTT assay,
cells exposed to Aβ for 6 h were further incubated with 0.33 mg/mL
XTT and 8.3 μM phenazine methosulfate (PMS) (Acros, Morris Plains,
NJ) for 2 h at 37 °C. The extent of XTT reduction was measured by
absorbance of reduced form of XTT at 467 nm. The cell-free XTT assay
was done in parallel to the cell stimulation studies, in a similar manner as
above except the Aβ sample was incubated with XTT and PMS without
any cells at the same final concentration of 15 μM for 6 h.
Statistical Analysis. Cellular responses and protofibril length
measurements were evaluated for statistical differences by paired t test
analysis in SigmaPlot 10.0 software.
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